Knight Closes US$50 Million Revolving Credit Facility with NBC

Core Viewpoint - Knight Therapeutics Inc. has secured a revolving credit facility with National Bank of Canada to support its growth strategy and acquisition plans, particularly for the Paladin acquisition [1][2][4]. Group 1: Credit Facility Details - The initial borrowing limit of the credit facility is up to US$50 million, with plans to increase it to at least US$100 million plus an accordion of US$50 million within the next six months [2][5]. - The credit facility can be drawn in either USD or CAD at the SOFR or CORRA rate plus a margin of 1.25% to 2.75%, depending on the company's debt leverage [3]. - The facility has an initial term of three years, extendable annually, and includes customary financial and non-financial covenants [2][3]. Group 2: Company Strategy and Leadership Statements - The credit facility is intended to enhance the company's operational strength and balance sheet, enabling it to pursue acquisition opportunities and support business growth in Latin America and Canada [4][5]. - The CFO of Knight Therapeutics expressed that the facility will optimize the capital structure and provide necessary funding for growth [5].